Article

362 views
KEY POINTS First independent assessment of the global work has been performed to tackle Antimicrobial Resistance (AMR) worldwide. GlaxoSmithKline and ...
Authentic, Ad-free Reporting
High-quality, Exclusive Content
Original Market Research Reports
Original Resources & Databases
Global Surveys & Guidelines
Lowest Subscription Pricing

Healthcare News You Won't Read Elsewhere

Most up-to-date information, original and in-depth reviews, full-length exclusive market reports and forecasts, full-access to the smart knowledge base centres, useful resources and databases.

Access articles & resources worth up to $4000.

KEY POINTS First independent assessment of the global work has been performed to tackle Antimicrobial Resistance (AMR) worldwide. GlaxoSmithKline and ...

You have read of your 8 free articles this month.

Subscribe to
Medgenera All-Access

Enjoy unlimited access to all contents, resources, exclusive market research reports, databases, surveys and many more features by subscribing to Medgenera All-Access.

Access articles & resources worth up to US $4, 000 per month.

Authentic, Ad-free Reporting
High-quality, Exclusive Content
Original Market Research Reports
Original Resources & Databases
Global Surveys & Guidelines
Lowest Subscription Pricing

Healthcare News You Won't Read Elsewhere

Most up-to-date information, original and in-depth reviews, full-length exclusive market reports and forecasts, full-access to the smart knowledge base centres, useful resources and databases.

Access articles & resources worth up to $4000.

More in TOP IN INDUSTRY


NEWLY PUBLISHED

Top Companies Leading the Rare Disease Drug Discovery (2018)

KEY POINTS Here are the six companies playing on the front foot in the segment of rare diseases drug discovery. ...

NEWLY PUBLISHED

World’s 10 Top-Selling Orphan Drugs 2018

KEY POINTS Here are the 10 top-selling orphan drugs in terms of their worldwide sales in the previous financial year. ...

NEWLY PUBLISHED

10 Potential Drugs in Development for Alzheimer’s Disease (2018)

KEY POINTS Here are the potential Alzheimer’s disease drug candidates in the late stage of clinical development in 2018. Companies ...

TOP IN INDUSTRY

The Front Runners Drug Companies in Tackling ‘Superbugs’

KEY POINTS First independent assessment of the global work has been performed to tackle Antimicrobial Resistance (AMR) worldwide. GlaxoSmithKline and ...

Most Popular


GROW

7 New Ideas to Start a Healthcare Business in India (2018)

Seven new #healthcare #business ideas in India in 2018. Which one would you prefer to pursue?

NEWLY PUBLISHED

Pharma Patents: Can India Reward Incremental Innovation?

Chandramouli Natarajan is an Associate Scientist, Ricon pharma LLC, Denville, USA. He has presented his opinion and views on the Pharmaceutical patents issues in India. This article is available for free to read and share.